The Third International Human Genome Editing Summit took place on 6-8 March 2023 in London focusing on the governance of gene editing research and recognizing the need to build on existing guidelines to develop global standards for governance and oversight of human genome editing. 

During the Second International Summit on Human Genome Editing in Hong Kong, in 2018, a prospect of an international legally binding treaty to govern genome editing was raised which did not preceded further.  

Gene editing regulations will consider the aims and consequences of the different practices like Somatic genome editing interventions and Heritable genome editing (germ-line editing).

 The Oviedo Convention, a legally binding instrument established by the European Council, permits somatic genome modifications for preventive, diagnostic, or therapeutic purposes, and prohibits germ-line editing, but only 29 countries have enacted it into law. 

To protect legitimate genetic research—to close loopholes in regulations and establish a global consensus on oversight and regulation—will require governance that is as dynamic as the science.